Ispire Technology Inc. Files Amendment No. 1 to S-1 Registration Statement

TL;DR

<b>Ispire Technology Inc. has filed an amendment to its S-1 registration statement, indicating ongoing efforts to register securities.</b>

AI Summary

Ispire Technology Inc. (ISPR) filed a Amended IPO Registration (S-1/A) with the SEC on March 18, 2024. Ispire Technology Inc. filed an amendment (No. 1) to its Form S-1 Registration Statement on March 18, 2024. The filing pertains to the Securities Act of 1933, with registration number 333-276804. The company's principal executive offices are located at 19700 Magellan Drive, Los Angeles, CA 90502. Michael Wang is listed as Co-Chief Executive Officer. The SIC code for the company is 2111 (Cigarettes).

Why It Matters

For investors and stakeholders tracking Ispire Technology Inc., this filing contains several important signals. This amendment suggests that Ispire Technology Inc. is actively working towards a public offering or other securities-related transactions, requiring updated regulatory filings. The S-1 filing is a crucial step for companies planning to go public or issue new securities, providing detailed information to potential investors and the SEC.

Risk Assessment

Risk Level: low — Ispire Technology Inc. shows low risk based on this filing. The filing is an amendment to a registration statement, which is a standard procedural step and does not inherently indicate significant new risks or positive developments.

Analyst Insight

Monitor future filings for details on the proposed offering, including the number of shares, pricing, and use of proceeds, to assess investment potential.

Key Numbers

• 1 — Amendment Number (Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT)
• 20240318 — Filing Date (FILED AS OF DATE: 20240318)
• 333-276804 — Registration Number (Registration No. 333-276804)
• 2111 — SIC Code (CIGARETTES [2111])

Key Players & Entities

• Ispire Technology Inc. (company) — Registrant
• Michael Wang (person) — Co-Chief Executive Officer
• 333-276804 (regulator) — Registration No.
• 19700 Magellan Drive, Los Angeles, CA 90502 (company) — Principal executive offices address
• 2111 (regulator) — SIC Code

FAQ

Industry Context

The company operates within the tobacco product manufacturing industry, specifically classified under SIC code 2111 (Cigarettes).

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities offerings in the United States.

What Investors Should Do

1. Review the full S-1/A filing for details on the securities being registered and the purpose of the offering.
2. Track future SEC filings from Ispire Technology Inc. for updates on the registration effectiveness and any subsequent offering activities.
3. Analyze the company's business model and financial health in conjunction with this registration filing.

Year-Over-Year Comparison

This is an amendment to a previous filing, indicating updates or additions to the initial registration statement.

Key Financial Figures

• $0.0001 — 4 shares of our common stock, par value $0.0001 per share ("common stock"), at an assum
• $9.36 — at an assumed public offering price of $9.36 per share (the last reported sale price
• $575,000 — ement agent fees, will be approximately $575,000. The delivery of the shares of common
• $20.5 billion — tinues to grow and is expected to reach $20.5 billion in 2031 according to Transparency Marke
• $10 million — Our contribution to NewCo will be up to $10 million in funding to support research and deve
• $9.00 — ur common stock at an exercise price of $9.00 per share. The Term Sheet requires th

Filing Documents

• ea0201856-01.htm (S-1/A) — 569KB
• ea020185601ex1-1_ispire.htm (EX-1.1) — 99KB
• ea020185601ex5-1_ispire.htm (EX-5.1) — 8KB
• ea020185601ex10-13_ispire.htm (EX-10.13) — 189KB
• ea020185601ex23-1_ispire.htm (EX-23.1) — 5KB
• ea020185601ex23-3_ispire.htm (EX-23.3) — 4KB
• ea020185601ex-fee_ispire.htm (EX-FILING FEES) — 16KB
• timage_001.jpg (GRAPHIC) — 207KB
• ex5-1_001.jpg (GRAPHIC) — 3KB
• ex23-1_001.jpg (GRAPHIC) — 16KB
• ex23-1_002.jpg (GRAPHIC) — 2KB
• ex23-1_003.jpg (GRAPHIC) — 1KB
• ex23-3_001.jpg (GRAPHIC) — 9KB
• ex23-3_002.jpg (GRAPHIC) — 3KB
• ex23-3_003.jpg (GRAPHIC) — 9KB
• 0001213900-24-023359.txt (&nbsp;) — 1626KB
• ispr-20231231.xsd (EX-101.SCH) — 3KB
• ispr-20231231_def.xml (EX-101.DEF) — 6KB
• ispr-20231231_lab.xml (EX-101.LAB) — 9KB
• ispr-20231231_pre.xml (EX-101.PRE) — 6KB
• ea0201856-01_htm.xml (XML) — 2KB

USE OF PROCEEDS

USE OF PROCEEDS 10

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 12 PLAN OF DISTRIBUTION 15 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 21 WHERE YOU CAN FIND MORE INFORMATION 22 LEGAL MATTERS 22 EXPERTS 22 i Table of Contents ABOUT THIS PROSPECTUS We incorporate by reference important information into this prospectus. You may obtain the information incorporated by reference without charge by following the instructions under " Where You Can Find More Information." You should carefully read this prospectus as well as additional information described under " Incorporation of Certain Information by Reference ," before deciding to invest in our common stock. We have not, and the placement agents have not, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the common stock offered hereby, and only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. Any representations, warranties and covenants made by us in any document that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Accordingly, such representations, warranties and covenants should not be relied

View Full Filing

View this S-1/A filing on SEC EDGAR